index - Équipe Biomarqueurs Radiopharmaceutiques et Neurochimiques

Derniers dépôts

Documents en texte intégral

66

Notices

63

 

Mots clés

Magnetic resonance imaging Proteinopathies Multiple system atrophy 5-HT 1A receptors Alert system A-BETA Animal models Alzheimer's disease Neuroinflammation Noradrenaline Sniffing Olfaction Positron emission tomography Animal model Amyloid-beta peptides Atmospheric pollution Alpha-synuclein Central nervous system Remote memory Radiotracer Alzheimer’s disease Biomarkers Amyloid Bayesian inference Autoimmune encephalitis 18FFluorodeoxyglucose Aβ42 Creutzfeldt-Jakob disease Alzheimer diagnosis PET Biomarkers neuroinflammation positron emission tomography Accident vasculaire cérébral 3D virtual histopathology Biased agonism System-level consolidation PET imaging Recent memory 11CPF-3274167 Autoradiography Dementia PET/MRI BIOMARKAPD Analytical confounders 18FFDG micro PET Acute ischemic stroke Drug discovery Automation Biomarker Amyotrophic lateral sclerosis Synucleinopathies Pharmaco-fUS Adverse events 5-HT6 receptor Brain Inflammation Parkinson's disease Piriform cortex Amyloid-beta Binding Magnetic resonance elastography Fibril aggregates Amyloid-β plaques Multiple sclerosis Biomarqueurs TEP 18 FF13640 5-HT 6 receptor Α2-adrenergic receptors 11Cyohimbine Anxiety behavior Blood biomarker Neuropharmacology Atomoxetine 14-3-3 protein Neurodegenerative diseases 5-Ht1A and 5-HT6 receptors Frontotemporal lobar degeneration Striatum Cerebrospinal fluid Non-human primate Power law exponent Locus coeruleus Agonists MicroPET Aβ40 Agonist 5-HT1A receptors Attention-deficit hyperactivity disorder 18FFDG Anti-CD20 Agonistes 18F-florbetapir Neuroimaging 5-HT1A Alzheimer Middle cerebral artery occlusion Amyloid‐β Serotonin Stroke